Effects of an acidic enteral formula containing two types of prebiotics on the intestinal environment and the antibody titers in enterally fed patients: an open-label, randomized controlled trial
Not Applicable
- Conditions
- influenza, diarrhea, constipation
- Registration Number
- JPRN-UMIN000013593
- Lead Sponsor
- Fukushimura Hospital
- Brief Summary
Bifidobacterium counts increased significantly in F group compared with C group. Few subjects in this study attained seroprotective titers against A/H3N2 and B antigens after influenza vaccination in either group, though the seroprotective rates against A/H1N1 were enhanced. The enhanced HI antibody titers against A/H1N1 were maintained in F group for a longer period compared with C group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with gastrointestinal disorders such as diarrhea, diabetes, nephropathy, severe infection, autoimmune disease, immunodeficiency, hepatic failure, and cow's milk allergy or soybean allergy. 2. other patients judged as inappropriate for the study by the physician in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method